Carcinoembryonic Antigen, and it is Commonly Referred to by its Abbreviation ?CEA? in Medical and Scientific Contexts
Received Date: Sep 01, 2023 / Published Date: Sep 28, 2023
Abstract
Carcinoembryonic Antigen (CEA) is a glycoprotein that was originally discovered as a tumor marker in cancer research. It is a cell surface protein that is overexpressed in various cancers, particularly colorectal carcinoma, but can also be found at lower levels in healthy tissues. CEA has been extensively studied for its utility in cancer diagnosis, prognosis, and monitoring, as well as its potential as a therapeutic target. This abstract provides an overview of the structure, function, clinical significance, and current research related to CEA, highlighting its role in cancer management and its potential applications in the field of oncology.
Citation: Min Z (2023) Carcinoembryonic Antigen, and it is Commonly Referred to by its Abbreviation “CEA” in Medical and Scientific Contexts. J Cancer Diagn 7: 198. Doi: 10.4172/2476-2253.1000198
Copyright: © 2023 Min Z. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
黑料网 Journals
Article Tools
Article Usage
- Total views: 633
- [From(publication date): 0-2023 - Nov 22, 2024]
- Breakdown by view type
- HTML page views: 550
- PDF downloads: 83
